Cannabis-Cultural and Social Commentaries
Cannabis-Cultural and Social Commentaries
Ganja in Jamaica Project Books and Articles Legal Archive Cultural/Social Commentaries News Archive Report
Articles on Cannabis and Perspectives
- Devane (1994). Current Awareness. New Dawn of Cannabinoid Pharmacology. February, 1994. Trends in Pharmacological Sciences.
- Dreher, Melanie C., PhD; Kevin Nugent, PhD; and Rebekah Hudgins, MA (1994).Prenatal Marijuana Exposure and Neonatal Outcomes in Jamaica: An Ethnographic Study Pediatrics, February 1994, Volume 93, Number 2, pp. 254-260. American Academy of Pediatrics
- Doblin & Kleiman (1991) Marijuana as Antiemetic Medicine: A Survey of Oncologists’ Experiences and Attitudes. Journal of Clinical Oncology, vol 9, no 7 (July), 1991: pp 1314-1319.
- Grinspoon, Lester (ed.) (1987) Marijuana. The Harvard Medical School Mental Health Letter. Volume 4, Number 5, November 1987.
- Husain, S and Kahn, I (1985) An update on cannabis research. . World Health Organization, Geneva, Switzerland. 1985/01/01
- Johnson & Gerstein (1998) Inition of Use of Alcohol, Cigarettes, Marijuana, Cocaine, and Other Substances in US Birth Cohorts since 1919. American Journal of Public Health, Jan 1998, vol 88 No 1.
Joy, Janet E., Stanley J. Watson, Jr., and John A. Benson, Jr., Editors (1999). Marijuana and Medicine: Assessing the Science Base. By .
Division of Neuroscience and Behavioral Health – Institute of Medicine. National Academy Press, Washington, D.C. 1999
Preface and Executive Summary
Chapter 1 Introduction
Chapter 2 Cannabinoids and Animal Physiology: Parts A / B / C
Chapter 3 First Do No Harm: Consequences of Marijuana: Parts A / B
Chapter 4 The Medical Value of Marijuana and Related Substances: Parts A / B
Chapter 5 Development of Cannabinoid Drugs
- Liskow, Barry I. (1973) Review of Nahas’ book: Marijuana: Deceptive Weed. JAMA, p. 630, April 1973 vol 224 No 5.
- Mathre, Mary Lynn (1997). Medicinal Use of Marijuana. AJN, November 1997, vol 97, no 11.
- Nahas, G. G. (1985) Critique of a study on ganja in Jamaica. United Nations Office for Drug Control and Crime Prevention. <http://www.undcp.org/bulletin/bulletin_1985-01-01_4_page004.html>
- Schaeffer, Jeffrey et. al. (1981). Cognition and Long-Term Use of Ganja (Cannabis) Reprint Series 24 July 1981, Volume 213, pp. 465-466 SCIENCE
- Schwartz, Richard et.al (1997) Marijuana to Prevent Nausea and Vomiting in Cancer Patients: A Survey of Clinical Oncologists. Southern Medical Journal. February 1997, vol 90, No 2.
- Silverstein & Lessin (1974) Normal Skin Test Responses in Chronic Marijuana Users. Science, vol 186, 740, 1974.
- Skidmore et.al (1997) Marijuana as Medicine (letters). AJN, May 1998, vol 98, No 5.
- US National Drug Strategy Monograph Series No. 25: The health and psychological consequences of cannabis use (chapters 1 to 9)
- Zimmer, Lynn (1995) Exposing Marijuana Myths: A Review of the Scientific Evidence. The Lindesmith Center, 1995.
- Zinberg, Norman (1976) Review, Marijuana. Psychology Today, December 1976.
Articles on Cannabis and Apoptosis and Proliferation
- Bisogno et.al (1998). Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer and rat pheochromocytoma cells – Implications for cell proliferation and differentiation. Eur. J. Biochem. 254, 634-642 (1998).
- DePetrocellis et.al (1998) The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proc. Natl. Acad. Sci. USA, Vol 95, pp. 8375-8380, July 1998, Pharmacology.
- Labit-Le Bouteiller et.al (1998). Antiproliferative effects of SR31747A in animal cell lines are mediated by inhibition of cholesterol biosynthesis at the steral isomerase step. Eur. J. Biochem. 256, 342-349 (1998).
- National Institute of Health (1996). NTP Technical report on the Toxicology and Carcinogenesis Studies of 1-trans-delta9-tetrahydrocannabinol. NTP TR 446, November 1996.
- Sanchez et.al (1998). Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells. FEBS Letters 436 (1998) 6-10.
- Schwartz et.al (1994). Anadamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis. J. Neuroimmunology 55 (1994) 107-115.
- Zhu et.al (1998). Delta9-tetrahydrocannabinol induces apoptosis in macrophages and lymphocites: involvement of Bcl-2 and Caspase-1. J. Pharmacology and Experimental Therapeutics. 286:1103-1109, 1998.
Articles on Cannabis and Receptors
- Bayewitch et.al (1996). (-)-Delta9-tetrahydrocannabinol antagonizes the peripheral cannabinoid receptor-mediated inhibition of adenylyl cyclase. J. Biol. Chemistry. Vol 271, No 17, April 26, pp. 9902-9905, 1996.
- Bonhaus et.al (1998). Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: evidence for agonistic-specific trafficking of intracellular responses. J.Pharmacology and Experimental Therapeutics, Vol 287, No 3, pp. 884-888, 1998.
- Brodkin et.al (1997). SR141716A Antagonizes the disruptive effects of cannabinoid ligands on learning in rats. J. Pharmacology and Experimental Therapeutics 282:1526-1532, 1997/
- Chapman et.al (1998). N-Acylethanolamines: Formation and molecular composition of a new class of plant lipids. Plant Physiol. (1998) 116:1163-1168.
- Devane et.al (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, Vol 258, December 1992
- Edgemond et.al (1998) Synthesis and characterization of diazomethylarachidonyl ketone: an irreversible inhibitor of N-arachidonylethanolamine amidohydrolase. J. Pharmacol. Exp. Ther. 286:184-190, 1998.
- Felder et.al (1992). Cannabinoid agonists stimulate both receptor and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones. Mol. Pharmacology, 42: 838-845, 1992.
- Felder et.al (1998) LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation. J. Pharmacol. Exp. Ther., 284:291-297, 1998.
- Fellermeier et.al (1998). Prenylation of olivetolate by a hemp transferase yields cannabigerolic acid, the precursor of tetrahydrocannabinol. FEBS Letters 427 (1998) 283-285.
- Fride & Mechoulam (1993). Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. Eur. J. Pharmacology, 231 (1993) 313-314.
- Griffin et.al (1998). Evaluation of cannabinoid receptor agonists and antagonists using the guanosine-5′-0-(3-[35S]thio)-triphosphate binding assay in rat cerebellar membranes. J. Pharmacol. Exp. Ther. 285:553-560, 1998.
- Mallet et.al (1998) The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta9-tetrahydrocannabinol. Psychopharmacology (1998) 140:11-19.
- Pop & Brewster (1997) Dimerization of dexanabinol by hydrogen bonding acounts for its hydrophobic character. Int. J. Quantum Chemistry, vol 65, 1057-1064 (1997).
- Rinaldi-Carmona et.al (1998) SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J. Pharmacol. Exp. Ther., 284:644-650, 1998.
- Smith et.al (1994). The pharmacological activity of anandamine, a putative endogenous cannabinoid, in mice. J. Pharmacol. Exp. Ther., vol 270, No 1, pp. 219-227.
- Stella et.al (1997). A second endogenous cannabinoid that modulates long-term potentiation. Nature, Vol 388, August 1997.
- Thomas et.al (1998). Comparative receptor binding analyses of cannabinoid agonists and antagonists. J. Pharmacol. Exp. Ther., 285:285-292, 1998.
- Welch et.al (1998). Differential Blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A. J. Pharmacol. Exp. Ther., 286:1301-1308.
- Wiley et.al (1998). Structure-activity relationships of indole- and pyrrole-derived cannabinoids. J. Pharmaco. Exp. Ther., 285:995-1004, 1998.
- Xie et al. (1996). The conformational properties of the highly selective cannabinoid receptor ligand CP-99,540. JBiolChem, vol 271, No 18, May 3, 1996, pp. 10640-10647.
- Adams et.al (1998). Assessment of anandamine interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain. J. Pharmacol. Exp. Ther., 284:1209-1217, 1998.
- Beltramo et.al (1997). Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science, Vol 277, 22 Aug 1997.
- Bisogno et.al (1997). Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells. Biochem. J. 322:671-677, 1997.
- Cadas et.al (1996). Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP. J. Neuroscience, June 15, 1996, 16(12):3934-3942.
- Cadas et.al (1997). Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain. J. Neuroscience, February 15, 1997, 17(4):1226-1242.
- Compton et.al (1997). The effect of the enzyme inhibitor phenylmethylsulfonyl fluoride on the pharmacological effect of anandamide in the mouse model of cannabimimetic activity. J. Pharmacol. Exp. Ther., 283:1138-1143, 1997.
- Deutsch et.al (1997). Production and physiological actions of anandamide in the vasculature of the rat kidney. J. Clin. Invest. Vol 100, No 6, September 1997, 1538-1546.
- Di Marzo et.al (1996). Biosynthesis of anandamide and related acylethanolamides in mouse J774 macrophages and N18 neuroblastoma cells. Biochem. J. (1996) 316, 977-984.
- Edgemond et.al (1998a) Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide). Mol. Pharmacology, 54:180-188 (1998).
- Giuffrida & Piomelli (1998). Isotope dilution GC/MS determination of anandamide and other fatty acylethanolamides in rat blood plasma. FEBS Letters, 422 (1998) 373-376.
- Goparahu et.al (1998). Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand. FEBS Letters, 422 (1998), 69-73.
- Kempe et.al (1996). Isotope dilution mass spectrometric measurements indicate that arachidonylethanolamide, the proposed endogenous ligand of the cannabinoid receptor, accumulates in rat brain tissue post morten but is contained at low levels in or is absent from fresh tissue. J. Biol. Chemistry, Vol 271, No 29, July 19, pp. 17287-17295.
- Kondo et.al (1998). 2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist: identification as one of the major species of monoacylglycerols in various rat tissues, and evidence for its generation through Ca2+-dependent and -independen mechanisms. FEBS Letters, 429 (1998) 152-156.
- Sugiura et.al (1996). Transacylase-mediated and phosphodiesterase-mediated synthesis of N-arachidonoylethanolamine, an endogenous cannabinoid-receptor ligand, in rat brain microsomes. Eur. J. Biochemistry, 240, 53-62 (1996).
- Ueda et.al (1995). Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide. J. Biol. Chemistry, Vol 270, No 40, October 6, 1995, pp. 23823-23827.
- Willoughby et.al (1997). The biodisposition and metabolism of anandamide in mice. J. Pharmacol. Exp. Ther. 282:243-247, 1997.
- Abood & Martin (1996). Molecular neurobiology of the cannabinoid receptor. Int. Rev. Neurobiology, vol 39(?), pp. 197-221.
- Breivogel et.al (1997). Regional differences in cannabinoid receptor/G-protein coupling in rat brain. J. Pharmacol. Exp. Ther. 282:1632-1642, 1997.
- Di Marzo et.al (1998). Interactions between synthetic vanilloids and the endogenous cannabinoid system. FEBS Letters 436 (1998) 449-454.
- Facci et.al (1995) Mast cells express a peripheral cannabinoid receptor with differemtial sensitivity to anandamine and palmitoylethanolamide. Proc. Natl. Acad. Sci. Vol 92, pp. 3376-3380. April 1995, Pharmacology.
- Garcia et.al (1998) Protein kinase C disrupts cannabinoid actions by phosphorylation of the CB1 cannabinoid receptor. J. Neuroscience, April 15, 1998, 18(8):2834-2841.
- Gifford et.al (1999). Large receptor reserve for cannabinoid actions in the central nervous system. J. Pharmacol. Exp. Ther. 288:478-483, 1999.
- Glass & Felder (1997) Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. J. Neuroscience, July 15, 1997, 17(14):5327-5333.
- Howlett et al. (1990) Classical and nonclassical cannabinoids: mechanisms of action-brain binding. NIDA Res Monogr Ser 1990;96:100-110.
- Howlett et.al (1998) Characterization of CB1 cannabinoid receptors using receptor peptide fragments and site-directed antibodies. Mol. Pharmacology 53:504-510 (1998).
- Howlett et.al (1988). Nonclassical cannabinoid analgetics inhibit adenylate cyclase: development of a cannabinoid receptor model. Mol. Pharmacology, 33: 297-302.
- Matsuda et.al (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, Vol 346, 9 August 1990.
- Romero et.al (1997). Atypical location of cannabinoid receptors in white matter areas during rat brain development. Synapse 26:317-323 (1997).
- Romero et.al (1998) Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta9-tetrahydrocannabinol. Synapse 30: 298-308 (1998).
- Shire et.al (1996) Structural features of the central cannabinoid CB1 receptor involved in the binding of the specific CB1 antagonist SR141716A. J. Biol. Chemistry, Vol 271, No 12, March 22, 1996, pp. 6941-6946.
- Sim et.al (1996) Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgamaS autoradiography in rat brain. J. Neuroscience, December 15, 1996, 16(24):8057-8066.
- Tao & Abood (1998) Mutation of a highly conserved aspartate residue in the second transmembrane domain of the cannabinoid receptors, CB1 and CB2, disrupts G-protein coupling. J. Pharmacol. Exp. Ther. 285:651-658, 1998.
- Felder & Glass (1998) Cannabinoid receptors and their endogenous agonists. Ann. Rev. Pharmacol. Toxicol. 1998 38:179-200.
- Glass et.al (1997) Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in fetal neonatal and adult human brain. Neuroscience, Vol 27, No 2, pp. 299-318.
- Hollister (1986) Health aspects of cannabis. Pharmacol. Reviews Vol. 38, No. 1, 1986.
- Hollister (1988) Cannabis. Acta Psychiatr. Rev. Suppl. 345, 1988:78-108.
- Howlett (1995) Pharmacology of cannabinoids receptors. Annu. Rev. Pharmacol. Toxicol. 1995 35:607-634.
Articles on Cannabis and Reproduction
- Dreher et.al (1994) Prenatal marijuana exposure and neonatal outcomes in Jamaica: an ethnographic study. Pediatrics, Vol. 93, No. 2, February 1994.
- Schmid et.al (1998) Changes in anandamide levels in mouse uterus are associated with uterine receptivity for embrio implantation. Proc. Nat’l. Acad. Science Vol. 94, pp. 4188-4192, April 1997, Physiology.
Articles on Cannabis and Synaptic Transmission
- Fan (1995) Cannabinoid agonists inhibits the activation of 5-HT(3) receptors in rat nodose ganglion neurons. J. Neurophysiology, Vol 73, No 2, February 1995.
- Henry et.al (1995) Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes. Neurosci. Letters 186 (1995) 91-94.
- Mackie et.al (1995) Cannabinoid activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J. Neuroscience, October 1995, 15(10): 6552-6561.
- Shen et.al (1996) Cannabinoid receptor agonists inhibit glutamatertgic synaptic transmission in rat hippocampal cultures. J. Neuroscience, July 15, 1996, 16(14):4322-4334.
- Twitchell et.al (1997) Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. J. Neurophysiology 022-3077/97